These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9856807)
21. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection]. Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Wright CD; Kennedy JA; Zitnik RJ; Kashem MA Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787 [TBL] [Abstract][Full Text] [Related]
23. Bacterial pneumonia causes augmented expression of the secretory leukoprotease inhibitor gene in the murine lung. Abe T; Tominaga Y; Kikuchi T; Watanabe A; Satoh K; Watanabe Y; Nukiwa T Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1235-40. PubMed ID: 9351627 [TBL] [Abstract][Full Text] [Related]
24. Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor. Thuraisingam T; Sam H; Moisan J; Zhang Y; Ding A; Radzioch D J Invest Dermatol; 2006 Apr; 126(4):890-901. PubMed ID: 16470178 [TBL] [Abstract][Full Text] [Related]
25. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. King AE; Critchley HO; Kelly RW Mol Hum Reprod; 2000 Feb; 6(2):191-6. PubMed ID: 10655462 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ. Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857 [TBL] [Abstract][Full Text] [Related]
27. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. Haase I; Hobbs RM; Romero MR; Broad S; Watt FM J Clin Invest; 2001 Aug; 108(4):527-36. PubMed ID: 11518726 [TBL] [Abstract][Full Text] [Related]
28. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. Odaka C; Mizuochi T; Yang J; Ding A J Immunol; 2003 Aug; 171(3):1507-14. PubMed ID: 12874244 [TBL] [Abstract][Full Text] [Related]
29. Secretory leukocyte protease inhibitor is a novel inhibitor of fibroblast-mediated collagen gel contraction. Sumi Y; Muramatsu H; Hata K; Ueda M; Muramatsu T Exp Cell Res; 2000 Apr; 256(1):203-12. PubMed ID: 10739667 [TBL] [Abstract][Full Text] [Related]
30. Targeted inhibition of wound-induced PAI-1 expression alters migration and differentiation in human epidermal keratinocytes. Li F; Goncalves J; Faughnan K; Steiner MG; Pagan-Charry I; Esposito D; Chin B; Providence KM; Higgins PJ; Staiano-Coico L Exp Cell Res; 2000 Aug; 258(2):245-53. PubMed ID: 10896775 [TBL] [Abstract][Full Text] [Related]
31. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347 [TBL] [Abstract][Full Text] [Related]
32. Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice. Kaiser S; Schirmacher P; Philipp A; Protschka M; Moll I; Nicol K; Blessing M J Invest Dermatol; 1998 Dec; 111(6):1145-52. PubMed ID: 9856831 [TBL] [Abstract][Full Text] [Related]